• Blog
  • News
  • 90 years of HA
  • Career
  • Eng
    • Fra
    • CN
    • KR
  • About us

    About us

    • Our Company & Values
    • Our History
    • Executive leadership
    • Our Production department
    • Our CSR Commitments
    • We Are Worldwide
    • Our Latest Investments
    • Compliance
  • Our Biopolymers
  • Our Premium Services
  • Innovation & R&D
  • Excellence in Quality
  • Our Industrial Platform
  • Contact
Press releases June 5, 2025

HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid

As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.

Read the article Close and continue
Home - News - Page 2

Read our news

Dive into the latest updates and happenings at HTL Biotechnology

Choix de la catégorie
  • Articles January 3, 2025

    Happy New Year 2025

    Happy New Year from HTL Biotechnology !

    Read more
  • Articles November 14, 2024

    Discover our new webpage dedicated to 90 years of HA and download our White Paper!

    and download our White paper now!

    Read more
  • Articles October 8, 2024

    HTL Biotechnology at CPHI Milano

    As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.

    Read more
  • Articles October 4, 2024

    1st symposium for HTL Biotechnology at MAIS congress

    As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.

    Read more
  • Articles October 3, 2024

    HTL Biotechnology will launch its White Paper at CPHI Milan!

    We are excited to announce that the HTL Biotechnology team will be attending CPHI Milan and on this occasion, we will be launching our White Paper to celebrate 90 years of discovery of Hyaluronic Acid!

    Read more
  • Articles October 1, 2024

    New Certification for HTL Biotechnology

    We are proud to announce that HTL Biotechnology has recently received Halal certification for two of our key products: DNA and HANa. Discover our press release.

    Read more
  • Articles July 5, 2024

    HTL Biotechnology Secures Medical Device Registration in China

    Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.

    Read more
  • Articles June 21, 2024

    HTL Biotechnology at CPHI China 2024

    CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,

    Read more
  • Articles June 13, 2024

    Discover our Quality Policy

    At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.

    Read more
  • Articles June 5, 2024

    National Bioproduction and Biomedicine Day (TVR report)

    On the occasion of the first National Bioproduction and Biomedicine Day, which took place on the last 5th july, we were very proud to welcome a TVR journalist in our Javené site for an exclusive report.

    Read more
  • Articles June 5, 2024

    New Ecovadis Gold label 2024

    We are delighted to announce that HTL Biotechnology has once again been awarded the EcoVadis Gold 2024 label for its Corporate Social Responsibility (CSR) performance!

    Read more
  • Press releases June 3, 2024

    BIOPHTA 6.5 million Euros Seed Funding

    BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.

    Read more
Learn more
  • Our Company & Values
  • Our History
  • Our Biopolymers
  • Innovation & R&D
  • Our Production department
  • Career
Contact us

Find us on social media

Social Media Group Policy

  • Terms & Conditions of Sale
  • Legal Notice & GTC
  • Privacy Policy
  • Cookies Policy
  • Sitemap

© HTL, 2024. All rights reserved